2
664
P. K. Mandal, A. K. Misra
PAPER
1
3
C NMR (75 MHz, CDCl ): d = 139.1–126.2 (Ar-C), 101.5
Methyl (3,4-Di-O-acetyl-6-O-tert-butyldimethylsilyl-2-deoxy-2-
phthalimido-b-D-glucopyranosyl)-(1→2)-3-O-benzyl-4,6-O-
benzylidene-a-D-glucopyranoside (22)
3
(
(
(
PhCH), 97.5 (C1), 94.5 (C1¢), 82.7, 82.2, 79.4, 77.7, 76.9, 75.9
PhCH ), 75.7 (PhCH ), 75.1 (PhCH ), 74.6, 73.3 (PhCH ), 73.0
PhCH ), 70.2, 69.2 (C6¢), 68.4 (C6), 62.5, 55.2 (OCH ).
2
2
2
2
To a soln of 8 (2.5 g, 6.7 mmol) and 11 (4.8 g, 8.7 mmol) in CH Cl
2
3
2
2
ESI-MS: m/z = 917.6 [M + Na]+.
(25 mL) was added 4 Å MS (3 g) and the mixture was stirred under
argon at r.t. for 30 min. NIS (2.3 g, 10.2 mmol) was added to the
mixture and it was cooled to –45 °C. To the cooled mixture
TMSOTf (40 mL, 0.22 mmol) was added by injection and stirring
continued at –45 °C for 30 min. The mixture was filtered through a
Celite bed. The filtrate was washed with 5% aq Na S O , sat.
Anal. Calcd for C H O (894.4): C, 73.81; H, 6.53. Found: C,
5
5
58 11
7
3.60; H, 6.90.
Methyl (2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosyl)-(1→2)-3-
O-benzyl-a-D-glucopyranoside (20)
To a soln of 19 (4 g, 4.5 mmol) in MeCN (50 mL) was added per-
chloric acid on silica gel (1 g) and the mixture was stirred at r.t. for
2
2
3
NaHCO , and H O, dried (Na SO ), and concentrated to a syrupy
3
2
2
4
product. Column chromatography of the crude product (silica gel,
hexane–EtOAc, 5:1) furnished pure 22 (4.5 g, 78%) as a syrup.
3
0 min. The mixture was filtered through a Celite bed and evaporat-
2
5
[
a]D +24.2 (c 1.5, CHCl3).
ed to dryness. Column chromatography of the crude product (silica
gel, hexane–EtOAc, 2:1) afforded pure 20 (3.24 g, 90%) as a syrup.
IR (neat): 2932, 1753, 1719, 1597, 1461, 1384, 1355, 1237, 1052,
761 cm .
–
1
25
[
a]D +33.7 (c 1.5, CHCl3).
1H NMR (300 MHz, CDCl
): d = 7.76–6.89 (m, 14 H, ArH), 5.77
–
1
3
IR (neat): 2926, 2366, 1596, 1459, 1352, 1070, 743 cm .
(
dd, J = 9.0, 9.0 Hz, 1 H, H3¢), 5.62 (d, J = 8.4 Hz, 1 H, H1¢), 5.41
1
H NMR (300 MHz, CDCl ): d = 7.41–7.11 (m, 25 H, Ar-H), 5.04–
3
(s, 1 H, PhCH), 5.13 (t, J = 9.3, 9.3 Hz, 1 H, H4¢), 4.95 (d, J = 3.6
Hz, 1 H, H1), 4.45 (dd, J = 8.4, 8.4 Hz, 1 H, H2¢), 4.36 (d, J = 12.0
Hz, 1 H, PhCH ), 4.22 (dd, J = 9.6, 4.2 Hz, 1 H, H3), 4.18 (d,
4
.96 (m, 2 H, PhCH ), 4.92 (d, J = 3.0 Hz, 1 H, H1), 4.87–4.82 (m,
2
2
1
H, PhCH ), 4.77–4.68 (m, 4 H, H1¢, PhCH ), 4.59 (d, J = 12.0 Hz,
2 2
2
H, PhCH ), 4.51 (d, J = 11.6 Hz, 1 H, PHCH ), 4.40 (d, J = 12.0
2
2
J = 12.0 Hz, 1 H, PhCH ), 3.82 (t, J = 9.3, 9.3 Hz, 1 H, H4), 3.80–
2
Hz, 1 H, PhCH ), 4.10–3.97 (m, 2 H, H3¢, H4¢), 3.92 (t, J = 9.0, 9.0
2
3.72 (m, 4 H, H5, H6 , H6¢ ), 3.68–3.62 (m, 2 H, H2, H6¢ ), 3.50 (t,
ab
a
b
Hz, 1 H, H4), 3.85–3.75 (m, 2 H, H2, H2¢), 3.71–3.52 (m, 5 H, H3,
J = 9.3, 9.3 Hz, 1 H, H5¢), 3.44 (s, 3 H, OCH ), 2.04,1.87 (2 s, 6 H,
3
H6 , H6¢ ), 3.47 (s, 3 H, OCH ), 3.45–3.41 (m, 2 H, H5, H5¢).
ab
ab
3
2 COCH ), 0.94 [s, 9 H, C(CH ) ], 0.10, 0.09 [2 s, 6 H, Si(CH ) ].
3
3 3
3 2
1
3
C NMR (75 MHz, CDCl ): d = 138.9–127.6 (Ar-C), 96.8 (C1),
13
3
C NMR (75 MHz, CDCl ): d = 170.4, 169.5 (2 COCH ), 167.7,
3 3
9
(
(
4.0 (C1¢), 81.9, 80.4, 79.2, 77.6, 75.9 (PhCH ), 75.5 (PhCH ), 74.9
2 2
PhCH ), 74.5, 73.3 (PhCH ), 72.7 (PhCH ), 70.9, 70.7, 70.3, 68.3
C6¢), 62.4 (C6), 54.9 (OCH3).
167.6 (2 CO, Phth), 138.8–123.8 (Ar-C), 101.7 (PhCH), 100.5 (C1),
2 2 2
100.1 (C1¢), 82.5, 81.8, 76.1, 75.3, 74.2 (PhCH ), 71.5, 69.7, 69.4
2
(C6¢), 62.8 (C6), 62.6, 55.9 (C2¢), 55.2 (OCH ), 26.3 [3 C,
3
ESI-MS: m/z: 829.6 [M + Na]+.
C(CH ) ], 21.0, 20.8 (2 COCH ), 18.7 [C(CH ) ], –4.9 [2 C,
3 3 3 3 3
Si(CH ) ].
3
2
Anal. Calcd for C H O (806.4): C, 71.44; H, 6.75. Found: C,
4
8
54 11
ESI-MS: m/z = 884.3 [M + Na]+.
7
1.20; H, 7.0.
Anal. Calcd for C H NO Si (861.3): C, 62.70; H, 6.43. Found: C,
4
5
55
14
Methyl (2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosyl)-(1→6)-
6
2.51; H, 6.65.
[
2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl-(1→2)]-3-O-ben-
zyl-a-D-glucopyranoside (21)
Methyl (3,4-Di-O-acetyl-2-deoxy-2-phthalimido-b-D-glucopyra-
nosyl)-(1→2)-3-O-benzyl-4,6-O-benzylidene-a-D-glucopyrano-
side (23)
To a soln of 5 (2.2 g, 3.4 mmol) and 20 (2.5 g, 3.1 mmol) in CH Cl
2
2
(
25 mL) was added 4 Å MS (3 g) and the mixture was stirred under
argon at r.t. for 30 min. NIS (925 mg, 4.1 mmol) was added to the
mixture and it was cooled to –45 °C. To the cooled mixture
TMSOTf (20 mL, 0.11 mmol) was added by injection and stirring
was continued at –45 °C for 30 min. The mixture was filtered
To a soln of 22 (3.0 g, 3.5 mmol) in AcOH (25 mL) was added 1 M
TBAF in THF (25 mL); the mixture was allowed to stir at r.t. for 6
h. The mixture was diluted with H O and extracted with CH Cl
2
2
2
(
3 × 50 mL). The organic layer was washed with sat. NaHCO and
2 2 4
3
through a Celite bed. The filtrate was washed with 5% aq Na S O ,
2
2
3
H O, dried (Na SO ), and concentrated to dryness to give the crude
sat. NaHCO , and H O, dried (Na SO ), and concentrated to a syr-
3
2
2
4
product. Column chromatography of the crude product (silica gel,
hexane–EtOAc, 3:1) furnished pure 23 (2.0 g, 75%) as a syrup.
upy product. Column chromatography of the crude product (silica
gel, hexane–EtOAc, 5:1) furnished pure 21 (3 g, 73%) as a syrup.
2
5
[
a]D –9 (c 1.5, CHCl3).
25
[
a]D +34.2 (c 1.5, CHCl3).
IR (neat): 2926, 2858, 1719, 1717, 1458, 1387, 1227, 1088, 1046,
–
1
IR (neat): 1595, 1351, 1066, 697 cm .
–1
9
94, 766 cm .
1
H NMR (300 MHz, CDCl ): d = 7.42–7.14 (m, 45 H, Ar-H), 5.06–
1
3
H NMR (300 MHz, CDCl ): d = 7.71–6.88 (m, 14 H, Ar-H), 5.65
3
5
.0 (m, 3 H, PhCH ), 4.98–4.95 (m, 2 H, PhCH ), 4.93–4.83 (m, 5
2
2
(d, J = 8.4 Hz, 1 H, H1¢), 5.62 (t, J = 8.4, 8.4 Hz, 1 H, H3¢), 5.44 (s,
1 H, PhCH), 4.96 (d, J = 3.6 Hz, 1 H, H1), 4.53–4.43 (m, 2 H, H2¢,
H, PhCH ), 4.82–4.74 (m, 4 H, H1, PhCH ), 4.70 (d, J = 2.0 Hz, 1
2
2
H, H1¢¢), 4.66 (d, J = 3.0 Hz, 1 H, H1¢), 4.60–4.50 (m, 5 H, PhCH2),
H4¢), 4.34 (d, J = 12.3 Hz, 1 H, PhCH ), 4.23 (dd, J = 9.9, 4.5 Hz, 1
2
4
3
.40–4.35 (t, J = 10.3 Hz, 1 H, H4), 4.14–3.98 (m, 2 H, H3¢, H4¢),
.97– 3.91 (m, 2 H, H2, H2¢), 3.88–3.81 (m, 4 H, H3, H3¢¢, H4¢¢,
H, H3), 4.21 (d, J = 12.3 Hz, 1 H, PhCH ), 4.10 (t, J = 7.2, 7.2 Hz,
2
1
H, H4), 3.89–3.81 (m, 1 H, H5), 3.79–3.65 (m, 5 H, H2, H6ab,
H2¢¢), 3.76–3.66 (m, 5 H, H6¢¢ , H6¢ H6 ), 3.64–3.53 (m, 4 H, H5,
a
ab,
ab
H6¢ ), 3.54–3.47 (m, 1 H, H5¢), 3.43 (s, 3 H, OCH ), 2.14, 1.94 (2
ab
3
1
3
H5¢, H5¢¢, H6¢¢ ), 3.50 (s, 3 H, OCH ). C NMR (75 MHz, CDCl3):
b
3
s, 6 H, 2 COCH3).
d = 138.1–127.9 (Ar-C), 97.6 (C1¢¢), 96.4 (C1), 94.0 (C1¢), 82.0,
1
3
C NMR (75 MHz, CDCl ): d = 171.7, 171.4 (2 COCH ), 167.9,
3
3
8
7
6
1.9, 80.4, 80.2, 80.0, 79.3, 77.7, 77.6, 76.0, 75.9, 75.5, 75.0, 74.9,
1
1
(
67.4 (2 CO, Phth), 138.7–123.8 (Ar-C), 101.7 (PhCH), 100.4 (C1),
00.3 (C1¢), 82.7, 82.2, 76.5, 74.5, 74.3 (PhCH ), 73.9, 69.9, 69.4
C6¢), 63.6 (C6), 62.6, 55.7 (C2¢), 54.9, 21.3, 21.0 (2 COCH3).
4.8, 74.4, 73.5, 73.4, 73.3 (9 PhCH ), 70.5, 70.2, 69.6, 68.8 (C6¢¢),
2
2
8.6 (C6), 68.2 (C6¢), 54.9 (OCH3).
ESI-MS: m/z = 1351.6 [M + Na]+.
ESI-MS: m/z = 770.3 [M + Na]+.
Anal. Calcd for C H O (1328.6): C, 74.08; H, 6.67. Found: C,
8
2
88 16
Anal. Calcd for C H NO (747.2): C, 62.64; H, 5.53. Found: C,
3
9
41
14
7
3.84; H, 6.95.
6
2.41; H, 6.85.
Synthesis 2007, No. 17, 2660–2666 © Thieme Stuttgart · New York